Clinical Trial Update: A Study to Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ocrelizumab plus methotrexate vs infliximab plus methotrexate in active rheumatoid arthritis patients who had insufficient response to …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Infliximab (infliximab)
• METHOTREXATE (METHOTREXATE)
• Ocrelizumab (ocrelizumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: TERMINATED | Results posted: 2020-11-06